We remind you that for any medical problem, you should consult your physician.
You wish to declare an adverse reaction related to a Substipharm product marketed in France:
You can report side effects directly via the national reporting system:
French National Agency for Medecines and Health Products Safety (Agence Nationale de Sécurité du Médicament et des produits de santé or ANSM) and Network of Regional Pharmacovigilance Centers : http://solidarites-sante.gouv.fr/soins-et-maladies/signalement-sante-gouv-fr
For any question related to a Substipharm product, please contact our Medical Information and Pharmacovigilance Service at + 33 4 67 10 58 49 or to the following email address : substipharm@vigipharm.fr
You wish to report a quality complaint related to a Substipharm product marketed in France:
Please contact us to following email address: qadistribution@substipharm.com
You wish to report a medical information inquiry related to a Substipharm product and/or its indications:
Please contact our Medical Information and Pharmacovigilance Service at + 33 4 67 10 58 49 or to the following email address : substipharm@vigipharm.fr